COMP <GO>
TMCI vs ANIK // EV/EBITDA & P/E VALUATION
Treace Medical Concepts Inc. (NASDAQ) VS. Anika Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: TMCI 3
— ANIK 6
■ METRIC PARITY
LAST: $5.06 (+4.76%) • MKT CAP: $329.1M
valuation
—
LAST: $21.79 (+1.11%) • MKT CAP: $291.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMCI VS. ANIK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TMCI | ANIK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.80% | 56.60% | +23.20 | TMCI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.40% | -10.20% | -22.20 | ANIK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.96% | 1.50% | -10.46 | ANIK | /fcf-yield <GO> |
| Operating Margin | -25.50% | -9.80% | -15.70 | ANIK | /operating-margins <GO> |
| Net Profit Margin | -27.70% | -9.80% | -17.90 | ANIK | /net-margins <GO> |
| Revenue Growth (YoY) | 1.60% | -5.90% | +7.50 | TMCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.90 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | ANIK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.6 | 53.1 | -1.53 | ANIK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $329.1M | $291.6M | $37.5M | TMCI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TMCI REV | ANIK REV | TMCI GROSS % | ANIK GROSS % | TMCI FCF | ANIK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $212.7M | $112.8M | 79.8% | 56.6% | -$29.5M | $4.4M |
| FY 2024 | $209.4M | $119.9M | 80.4% | 63.4% | -$48.8M | -$2.3M |
| FY 2023 | $187.1M | $120.8M | — | — | -$34.6M | -$1.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMCI // BETA —
ANIK // BETA —